無料プレビュー

Illumina, Inc. (ILMN) · NASDAQ Global Select

プロフィール

Illumina, Inc. is a global leader in sequencing- and array-based solutions for genetic and genomic analysis. The company develops and sells integrated sequencing and microarray instruments, consumables (reagents, flow cells, library preparation kits), bioinformatics software, and laboratory services. Its reportable operating segment, Core Illumina (following the June 2024 spin-off of GRAIL), serves research, clinical, and applied markets including academic institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and consumer genomics providers globally, with a substan

主要指標

株価: $264.57 (-1.19%)
時価総額: 400億ドル
PER（今期予想）: 49.4
PBR: 14.1
配当利回り: —
52週レンジ: $88.00 – $309.35
業種: Healthcare / Medical - Diagnostics & Research
上場: NASDAQ Global Select
構成銘柄: S&P 500 0.06%

比較会社: TMO Thermo Fisher Scientific Inc.、DHR Danaher Corporation、NTRA Natera, Inc.、A Agilent Technologies, Inc.、IQV IQVIA Holdings Inc.、WAT Waters Corporation、IDXX IDEXX Laboratories, Inc.、MTD Mettler-Toledo International Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-29 · 更新: 2026-10-08